Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Balance Sheets

v3.22.1
Unaudited Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 95,210 $ 104,484
Prepaid expenses and other current assets 3,919 3,569
Accounts receivable, net 1,628 861
Inventory 1,149 463
Total current assets 101,906 109,377
Other assets 5,543 6,122
Deferred offering costs 124 150
Restricted cash 218 218
Property and equipment, net 61 113
Intangible assets, net 961 1,056
Operating lease right-of-use asset (See Note 7) 2,749 2,801
Total assets 111,562 119,837
Current liabilities:    
Accounts payable 8,130 7,848
Accrued expenses 4,523 5,698
Other liabilities, current portion (See Note 6) 174 0
Warrant liabilities 40 0
Operating lease liability, current portion (See Note 7) 77 70
Total current liabilities 12,944 13,616
Other liabilities (See Note 6) 4,102 3,345
Warrant liabilities 7,921 18,062
Convertible debt and derivative liability (See Note 6) 10,817 11,607
Loan payable 33,713 28,745
Operating lease liability (See Note 6) 3,138 3,204
Total liabilities 72,635 78,579
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.001 par value, authorized 5,000,000 shares as of March 31, 2022 and December 31, 2021; 0 shares issued and outstanding as of March 31, 2022 and December 31, 2021 0 0
Common stock, $0.001 par value, 100,000,000 shares authorized as of March 31, 2022 and December 31, 2021; 29,221,158 and 28,705,334 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively 32 32
Additional paid-in capital 403,825 400,705
Accumulated deficit (364,930) (359,479)
Total stockholders’ equity 38,927 41,258
Total liabilities and stockholders’ equity $ 111,562 $ 119,837